Акрон logo
Акрон AKRN

Акрон Income Statement 2005-2025 | AKRN

Annual Income Statement Акрон

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005

Revenue

179 B 181 B 145 B 120 B 115 B 108 B 94.3 B 89.4 B 92 B 74.6 B 67.9 B 71.1 B 65.4 B 46.7 B 37.5 B 43.1 B 31.1 B 23.6 B 22.7 B

Cost Of Revenue

88.8 B 60.6 B 49.4 B 65.8 B 59.8 B 54.4 B 51.9 B 45.3 B 37.8 B 42.7 B 42 B 40.4 B 35.5 B 27.9 B 23.9 B 19.8 B 18.9 B 15.7 B 14 B

Gross Profit

90.7 B 120 B 95.5 B 54 B 55.1 B 53.6 B 42.4 B 44 B 54.2 B 31.9 B 25.9 B 30.7 B 30 B 18.9 B 13.6 B 23.4 B 12.2 B 7.97 B 8.8 B

Gross Profit Ratio

0.51 0.66 0.66 0.45 0.48 0.5 0.45 0.49 0.59 0.43 0.38 0.43 0.46 0.4 0.36 0.54 0.39 0.34 0.39

General and Administrative Expenses

32.1 B 681 M 529 M 1.04 B 1.01 B 974 M 833 M 862 M 1.08 B 876 M 938 M 856 M - - - - - 307 M 262 M

Selling And Marketing Expenses

51 M 7.77 B 3.7 B 22.9 B 22.4 B 19.4 B 15.2 B 13.7 B 13.4 B 10 B 8.54 B 7.92 B 6.74 B 5.67 B 4.31 B 3.77 B 133 M 323 M 225 M

Selling General And Administrative Expenses

32.2 B 8.45 B 4.22 B 24 B 23.5 B 25.1 B 20.3 B 19 B 16.3 B 10.9 B 9.48 B 8.77 B 6.74 B 5.67 B 4.31 B 3.77 B 133 M 630 M 486 M

Other Expenses

- 9.36 B 4.61 B 7.25 B 6.95 B -640 M -330 M -486 M -425 M -28 M -44 M -212 M 3.27 B 4.03 B 3.42 B -74.4 M 4.59 B 3.63 B 3.31 B

Operating Expenses

39.4 B 17.8 B 8.83 B 31.2 B 30.4 B 25.8 B 20.6 B 19.5 B 16.7 B 15.4 B 12.8 B 12.2 B 10 B 9.75 B 7.75 B 3.71 B 4.73 B 4.26 B 3.81 B

Cost And Expenses

128 B 78.4 B 58.3 B 97 B 90.2 B 80.2 B 72.5 B 64.8 B 54.5 B 58 B 54.9 B 52.7 B 45.5 B 37.6 B 31.7 B 23.5 B 23.7 B 19.9 B 17.8 B

Interest Expense

- 3.7 B 4.88 B 3.28 B 1.12 B 1.61 B 4.11 B 4.57 B 4.37 B 782 M 906 M 1.15 B 1.24 B 695 M 364 M 362 M 510 M 492 M 369 M

Depreciation And Amortization

12.5 B 12 B 237 K 12.1 B 11.3 B 9.03 B 7.96 B 6.1 B 4.22 B 3.87 B 2.57 B 1.97 B 1.92 B 1.5 B 1.38 B 1.34 B 1.01 B 924 M 873 M

EBITDA

68.7 B 119 B 103 B 21 B 44.1 B 29.6 B 31 B 42.7 B 28.7 B 13.4 B 20 B 23 B 28.9 B 10.4 B 10.5 B 15.3 B 9.07 B 4.89 B 5.89 B

EBITDA Ratio

0.38 0.66 0.74 0.2 0.37 0.34 0.32 0.34 0.45 0.04 0.21 0.31 0.31 0.23 0.28 0.37 0.29 0.21 0.26

Operating Income

56.2 B 95.8 B 107 B 12.5 B 23.4 B 27.9 B 21.8 B 24.5 B 37.5 B 21 B 14 B 18.7 B 19.9 B 9.1 B 5.86 B 19.6 B 7.43 B 3.71 B 4.98 B

Operating Income Ratio

0.31 0.53 0.74 0.1 0.2 0.26 0.23 0.27 0.41 0.28 0.21 0.26 0.3 0.19 0.16 0.46 0.24 0.16 0.22

Income Before Tax

51 B 92.1 B 97.7 B 5.41 B 31 B 18.3 B 17.8 B 31.6 B 19.8 B 8.47 B 15.9 B 19 B 25.5 B 8.18 B 8.8 B 13.6 B 7.55 B 3.47 B 4.65 B

Income Before Tax Ratio

0.28 0.51 0.67 0.05 0.27 0.17 0.19 0.35 0.22 0.11 0.23 0.27 0.39 0.18 0.23 0.31 0.24 0.15 0.2

Income Tax Expense

15.1 B 20.3 B 15.5 B 1.57 B 6.18 B 4.99 B 3.5 B 5.96 B 4.17 B 1.57 B 2.91 B 4.1 B 5.2 B 1.9 B 1.55 B 3.68 B 1.88 B 1.01 B 1.27 B

Net Income Ratio

0.2 0.4 0.57 0.03 0.21 0.12 0.14 0.29 0.16 0.06 0.18 0.2 0.28 0.12 0.19 0.22 0.16 0.1 0.13

Earnings Per Share, EPS

971 2 2.09 K 87.7 620 325 339 653 367 119 333 387 478 142 179 236 128 57 76.6

EPS Diluted

971 2 2.09 K 87.7 618 324 339 653 367 119 314 387 478 142 179 236 128 57 76.6

Weighted Average Shares Outstanding

36.8 M 36.8 B 39.3 M 37.7 M 39.1 M 39.3 M 39.6 M 39.9 M 40.1 M 36.7 M 36.8 M 36.7 M 43.2 M 39.3 M 39.5 M 39.5 M 39.6 M 39.6 M 39.6 M

All numbers in RUB currency

Quarterly Income Statement Акрон

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4

Revenue

51.4 B 48.9 B 42.6 B 35 B 37.9 B 59.7 B 49.9 B 51.2 B 47 B 39 B 33.8 B 29.7 B 28.4 B 28.1 B 25.2 B 29.1 B 31 B 29.5 B 30.3 B 28.4 B 25.4 B 24 B 25.1 B 22.4 B 22.8 B 24.1 B 22.6 B 19.9 B 23.6 B 27.6 B 25.4 B 28.6 B 24.4 B 27.7 B 22 B 16.9 B 18.4 B 17.4 B 16.2 B 17.4 B 17.7 B 16.6 B 17.6 B

Cost Of Revenue

26.3 B 22.7 B 22.4 B 21.2 B 17.4 B 19.2 B 21.4 B 17.3 B 14.6 B 17.9 B 18.8 B 15.1 B 14.4 B 17.6 B 13.6 B 15.8 B 15 B 15.4 B 13.4 B 14.5 B 13.7 B 12.8 B 14.1 B 12.8 B 12.1 B 12.8 B 13.5 B 10.1 B 12.5 B 13.4 B 10.2 B 14.2 B 13.3 B 12.4 B 11 B 10 B 11.2 B 10.4 B 11.2 B 11 B 10.4 B 9.44 B 11.2 B

Gross Profit

25.1 B 26.2 B 20.1 B 13.8 B 20.5 B 40.6 B 28.5 B 33.9 B 32.4 B 21.1 B 15 B 14.6 B 14 B 10.5 B 11.7 B 13.3 B 16 B 14.1 B 16.9 B 13.8 B 11.7 B 11.3 B 10.9 B 9.56 B 10.7 B 11.3 B 9.05 B 9.84 B 11.1 B 14.2 B 15.2 B 14.4 B 11.1 B 15.2 B 10.9 B 6.93 B 7.18 B 6.93 B 5.04 B 6.45 B 7.28 B 7.12 B 6.39 B

Gross Profit Ratio

0.488 0.535 0.473 0.394 0.54 0.679 0.572 0.662 0.69 0.541 0.443 0.491 0.493 0.374 0.462 0.456 0.516 0.478 0.557 0.487 0.46 0.468 0.436 0.427 0.469 0.468 0.401 0.494 0.471 0.515 0.598 0.503 0.456 0.551 0.497 0.409 0.39 0.4 0.311 0.37 0.411 0.43 0.362

General and Administrative Expenses

- 9.85 B - - 2.02 B 5.52 B - - - - 1.04 B - - - 1.01 B - - - 974 M - - - 833 M - - - - - - - 1.08 B - - - 876 M - - - - - - - -

Selling And Marketing Expenses

- 51 M - 2.49 B - 73 M - 8.02 B 11 B 8.24 B -604 M 8.49 B 8.43 B 6.61 B 883 M 7.33 B 7.24 B 7 B 1.34 B 6.29 B 6.41 B 5.36 B -194 M 4.8 B 5.18 B 5.43 B -1.54 B 5.8 B 4.98 B 5.56 B -728 M 4.66 B 4.6 B 4.83 B -564 M 3.6 B 3.66 B 3.34 B -1.42 B 3.49 B 3.19 B 3.27 B -1.82 B

Selling General And Administrative Expenses

14.7 B 9.9 B 7.93 B 2.49 B 2.02 B 5.59 B 5.75 B 8.02 B 11 B 8.24 B 431 M 8.49 B 8.43 B 6.61 B 1.9 B 7.33 B 7.24 B 7 B 2.31 B 6.29 B 6.41 B 5.36 B 639 M 4.8 B 5.18 B 5.43 B -674 M 5.8 B 4.98 B 5.56 B 355 M 4.66 B 4.6 B 4.83 B 312 M 3.6 B 3.66 B 3.34 B -479 M 3.49 B 3.19 B 3.27 B -963 M

Other Expenses

- - - - 2.77 B - - -89 M 33 M 71 M 6.88 B 123 M 152 M 145 M 6.79 B -27 M -15 M 208 M 5.1 B 831 M -747 M 59 M - -143 M -125 M -87 M 329 M -329 M -236 M -97 M -14 M -261 M 1.6 B -42 M 74 M 18 M 2.35 B -1.24 B 19 M -43 M -1.33 B -6 M 56 M

Operating Expenses

15.9 B 13.6 B 5.84 B 6.15 B 4.79 B 31.5 B 11.5 B 7.93 B 11.1 B 8.31 B 7.31 B 8.61 B 8.58 B 6.76 B 8.87 B 7.45 B 7.38 B 6.86 B 7.41 B 5.46 B 7.23 B 5.42 B 4.35 B 4.94 B 5.56 B 5.48 B 4.34 B 5.87 B 5.12 B 5.62 B 5.67 B 4.39 B 6.2 B 4.91 B 4.54 B 3.62 B 6 B 2.1 B 2.68 B 3.58 B 1.87 B 3.26 B 2.21 B

Cost And Expenses

42.2 B 36.4 B 28.3 B 27.4 B 22.2 B 50.7 B 32.8 B 25.2 B 25.7 B 26.2 B 26.1 B 23.7 B 22.9 B 24.3 B 22.4 B 23.3 B 22.4 B 22.2 B 20.8 B 20 B 20.9 B 18.2 B 18.5 B 17.8 B 17.7 B 18.3 B 17.9 B 15.9 B 17.6 B 19 B 15.9 B 18.6 B 19.5 B 17.3 B 15.6 B 13.6 B 17.2 B 12.5 B 13.8 B 14.6 B 12.3 B 12.7 B 13.5 B

Interest Expense

- - - 197 M 1.08 B - - 777 M 1.1 B 573 M 704 M 760 M 1.34 B 335 M - 617 M 780 M 148 M 754 M 486 M 228 M 971 M 921 M 948 M 1.02 B 1.22 B 1.56 B 879 M 1.09 B 1.18 B 1.3 B 1.34 B 1.2 B 530 M 55 M 131 M 516 M 80 M - 130 M 1.97 B 199 M -

Depreciation And Amortization

3.1 B 2.93 B 3.19 B 3.19 B 3.19 B 2.64 B 3.29 B 2.92 B 2.95 B 2.95 B 3.16 B 2.84 B 2.61 B 3.49 B 3.51 B 2.67 B 2.41 B 2.76 B 2.19 B 2.3 B 2.48 B 2.06 B 1.81 B 2.36 B 2.06 B 1.73 B 2.95 B 1.08 B 1.11 B 1.3 B 1.22 B 1.17 B 1.13 B 1.08 B 1.17 B 914 M 1 B 782 M 811 M 732 M 424 M 599 M 744 M

EBITDA

13.4 B 17 B 15 B 10.8 B 18.1 B 30.6 B 24.3 B 31 B 28.2 B 16.7 B 14.3 B -59 M 12.7 B -5.97 B 6 B 10.4 B 13.5 B 14.6 B 11.5 B 8.02 B 1.29 B 8.78 B 8.64 B 14.1 B 3.64 B 4.42 B 16.5 B 5.61 B 8.03 B 12.7 B 5.4 B 5.69 B 8.75 B 11.2 B 7.46 B 4.7 B 7.84 B 2.27 B 2.25 B 4.42 B 5.92 B 3.9 B 5.08 B

EBITDA Ratio

0.262 0.347 0.352 0.283 0.478 0.512 0.487 0.565 0.566 0.39 0.479 0.002 0.468 -0.183 0.29 0.287 0.397 0.482 0.296 0.305 0.18 0.324 0.325 0.315 0.218 0.391 0.447 0.282 0.34 0.46 0.333 0.195 0.4 0.406 -0.191 0.008 0.298 0.103 0.139 0.223 0.332 0.241 0.276

Operating Income

10.3 B 14 B 11.8 B 18.3 B 18.1 B 27.9 B 21 B 26.1 B 20.7 B 12.7 B 13 B -2.78 B 4.72 B 5.71 B 2.32 B 6.06 B 8.34 B 6.68 B 8.86 B 8.56 B 4.54 B 5.47 B 6.36 B 4.33 B 5.4 B 5.08 B 4.12 B 3.66 B 5.21 B 6.82 B 9.45 B 11.9 B 4.94 B 10.9 B 9.76 B 5.26 B 1.13 B 4.8 B 1.51 B 2.69 B 5.46 B 4.32 B 3.77 B

Operating Income Ratio

0.201 0.287 0.277 0.523 0.478 0.467 0.421 0.509 0.441 0.327 0.386 -0.094 0.167 0.203 0.092 0.208 0.269 0.226 0.293 0.302 0.179 0.227 0.254 0.193 0.237 0.211 0.183 0.184 0.221 0.247 0.372 0.417 0.202 0.396 0.444 0.311 0.062 0.277 0.093 0.154 0.308 0.261 0.214

Income Before Tax

8.4 B 12.4 B 14.5 B 3.15 B 17.1 B 8.26 B 16.4 B 27.2 B 24 B 13.1 B 10.4 B -3.76 B 8.74 B -9.95 B 2.49 B 7.12 B 10.1 B 11.2 B 8.39 B 5.17 B -1.55 B 5.47 B 5.52 B 10.4 B 453 M 1.4 B 12 B 2.43 B 1.64 B 15.9 B 2.88 B 3.02 B 6.42 B 8.23 B -2.91 B 3.66 B 6.32 B 1.4 B 5.74 B 3.56 B 3.52 B 3.11 B 4.34 B

Income Before Tax Ratio

0.164 0.254 0.341 0.09 0.45 0.138 0.329 0.53 0.511 0.337 0.307 -0.127 0.308 -0.354 0.099 0.244 0.327 0.381 0.277 0.182 -0.061 0.227 0.22 0.464 0.02 0.058 0.53 0.122 0.07 0.575 0.114 0.106 0.263 0.298 -0.133 0.216 0.344 0.081 0.354 0.204 0.199 0.188 0.246

Income Tax Expense

1.92 B 2.19 B 7.92 B -14 M 3.25 B 3.54 B 4.42 B 5.92 B 4.98 B 2.5 B 2.38 B -589 M -399 M 178 M 691 M 1.33 B 1.7 B 2.46 B 2.44 B 1.22 B 6 M 1.32 B 1.4 B 2.2 B 78 M -176 M 988 M 675 M 1.46 B 3.2 B 500 M 763 M 1.42 B 1.17 B -122 M 514 M 1.21 B -33 M 735 M 783 M 642 M 749 M 1.19 B

Net Income Ratio

0.126 0.209 0.154 0.091 0.364 0.077 0.237 0.411 0.401 0.269 0.233 -0.107 0.316 -0.365 0.07 0.193 0.265 0.292 0.19 0.135 -0.062 0.164 0.153 0.355 0.008 0.062 0.484 0.084 0.016 0.478 0.069 0.04 0.207 0.245 -0.193 0.146 0.289 0.048 0.304 0.152 0.144 0.126 0.17

Earnings Per Share, EPS

176 279 178 86.5 376 124 322 626 554 309 230 -92 262 -299 46.6 159 231 246 153 107 -44.2 110 107 221 2.71 43.5 289 46.3 216 350 46.5 32 141 184 -116 67.5 144 22.6 131 82.8 69.3 56.8 79.3

EPS Diluted

176 279 178 82.5 376 124 322 626 554 309 230 -92 251 -291 46.6 159 230 246 153 106 -44.2 110 106 219 2.23 43.5 289 46.3 216 350 46.5 32 141 184 -112 67.5 132 20.6 131 77.4 68.2 56 79.3

Weighted Average Shares Outstanding

36.6 M 36.7 M 36.8 M 36.7 M 36.8 M 37.1 M 36.8 M 33.6 M 34 M 33.9 M 34.2 M 34.5 M 34.2 M 34.2 M 37.7 M 35.5 M 35.6 M 35.6 M 37.7 M 35.7 M 35.7 M 35.7 M 35.6 M 35.9 M 35.8 M 36.1 M 36.1 M 36.4 M 33.6 M 36.2 M 36.7 M 35.7 M 35.9 M 36.8 M 36.4 M 36.8 M 36.8 M 36.8 M 36.8 M 32 M 36.8 M 36.8 M 36.8 M

All numbers in RUB currency

The income statement is one of the three key financial reports of a company Акрон (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Agricultural inputs industry

Issuer Price % 24h Market Cap Country
Bioceres Crop Solutions Corp. Bioceres Crop Solutions Corp.
BIOX
$ 1.56 -0.64 % $ 435 M argentinaArgentina
ФосАгро ФосАгро
PHOR
- - - russiaRussia
China Green Agriculture China Green Agriculture
CGA
- 0.51 % $ 27.6 M chinaChina
CF Industries Holdings CF Industries Holdings
CF
$ 78.57 -0.81 % $ 14.2 B usaUSA
ICL Group Ltd ICL Group Ltd
ICL
$ 4.97 -2.07 % $ 7.83 B israelIsrael
FMC Corporation FMC Corporation
FMC
$ 13.09 -5.86 % $ 1.64 B usaUSA
Corteva Corteva
CTVA
$ 65.62 -0.68 % $ 45.5 B usaUSA
American Vanguard Corporation American Vanguard Corporation
AVD
$ 4.05 -6.14 % $ 114 M usaUSA
Nutrien Ltd. Nutrien Ltd.
NTR
$ 61.9 -1.57 % $ 34.8 B canadaCanada
Intrepid Potash Intrepid Potash
IPI
$ 26.77 -1.29 % $ 345 M usaUSA
Marrone Bio Innovations Marrone Bio Innovations
MBII
- -5.9 % $ 180 M usaUSA
The Mosaic Company The Mosaic Company
MOS
$ 24.95 -4.84 % $ 7.98 B usaUSA
Yield10 Bioscience Yield10 Bioscience
YTEN
- 15.32 % $ 46.6 M usaUSA
Arcadia Biosciences Arcadia Biosciences
RKDA
$ 3.7 1.65 % $ 4.58 M usaUSA
Origin Agritech Limited Origin Agritech Limited
SEED
$ 1.32 -8.33 % $ 7.42 M chinaChina
The Scotts Miracle-Gro Company The Scotts Miracle-Gro Company
SMG
$ 58.34 1.08 % $ 3.36 B usaUSA
CVR Partners, LP CVR Partners, LP
UAN
$ 95.49 0.14 % $ 1.01 B usaUSA